Pharmaceuticals

Porcine Epidemic Diarrhea Vaccines Market 2026 expanding toward $2.5 billion by 2030

March 24, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Porcine Epidemic Diarrhea Vaccines Market Expected To Change Between 2026 And 2030?

The market for porcine epidemic diarrhea vaccines has demonstrated robust expansion recently. Projections indicate a rise in its valuation from $1.8 billion in 2025 to $1.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. Historically, this growth has been driven by factors such as recurrent outbreaks of porcine epidemic diarrhea, elevated mortality rates among neonatal piglets, financial setbacks experienced by the swine industry, the restricted efficacy of non-vaccine disease management strategies, and an increased dependence on veterinary-guided disease prevention.

The porcine epidemic diarrhea vaccines market is set to experience robust expansion over the next few years, with its size projected to reach $2.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This forecasted growth is primarily influenced by the rise of intensive pig farming practices, increasing global consumption of pork products, growing awareness of the benefits of herd immunity, the expansion of structured hog production farms, and supportive government initiatives for animal health. Significant trends expected during this period include a greater adoption of preventive vaccination in swine health management, a rising preference for live vaccines in regions where the disease is endemic, an increased focus on the early immunization of piglets, the broadening of vaccination programs in commercial hog farms, and an enhanced emphasis on biosecurity and disease control protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp

Which Major Factors Are Driving The Expansion Of The Porcine Epidemic Diarrhea Vaccines Market?

Growing pig farming is anticipated to drive the expansion of the porcine epidemic diarrhea vaccine market in the future. This sector encompasses the raising of domestic pigs for meat, including breeding, rearing, managing animals from birth to market weight, and the production and commercialization of pork items. The surge in pig farming is fueled by increasing global pork demand, enhancements in breeding and herd management techniques, technological strides in swine production systems, and the growth of commercial pork markets. Porcine epidemic diarrhea (PED) vaccines are vital for pig farming, assisting in the prevention and control of disease outbreaks, often administered during the sow’s gestation to confer passive immunity to newborn piglets. As an illustration, in April 2024, the U.S. Department of Agriculture, a US-based government agency, forecast U.S. pork production to hit 12.7 million metric tons. This projection signifies heightened swine output and underpins the ongoing growth of the pig farming industry. Consequently, the expansion of pig farming is stimulating the growth of the porcine epidemic diarrhea vaccine market.

How Is The Porcine Epidemic Diarrhea Vaccines Market Structured Across Different Segments?

The porcine epidemic diarrhea vaccines market covered in this report is segmented –

1) By Product: Live Vaccines, Killed Vaccines

2) By Application: Piglets, Adults Pigs

3) By End-User: Veterinary Hospitals, Hog Production Farms

Subsegments:

1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines

2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines

Which Trends Are Shaping The Future Of The Porcine Epidemic Diarrhea Vaccines Market?

Leading firms within the Porcine Epidemic Diarrhea (PED) vaccines market are concentrating on creating cutting-edge solutions, including next-generation inactivated and recombinant vaccines, to improve immunity and offer wider safeguarding against new PEDV strains. These next-generation inactivated and recombinant vaccines function by employing either deactivated viruses or genetically modified viral proteins to induce robust, specific immune responses, thereby increasing safety and defense against evolving disease strains. A notable example is Zoetis Inc., a US-based animal health company, which in August 2024, secured a grant for Porcine Epidemic Diarrhea Virus (PEDV) vaccine research and also obtained a conditional license from the U.S. Department of Agriculture (USDA) for a vaccine targeting PEDV in pigs. Such initiatives reinforce Zoetis’s position in crafting advanced swine health solutions by fostering additional research, boosting vaccine effectiveness, and broadening the scope of protection against emerging PEDV strains.

Which Major Players Dominate The Porcine Epidemic Diarrhea Vaccines Market?

Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, MSD Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Phibro Animal Health Corporation, IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc., Tecnovax, Komipharm International Co. Ltd., Bioveta a.s., HIPRA, CZ Vaccines

Read the full porcine epidemic diarrhea vaccines market report here:

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Which Region Currently Holds The Largest Share Of The Porcine Epidemic Diarrhea Vaccines Market?

Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2025. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Porcine Epidemic Diarrhea Vaccines Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16514&type=smp

Browse Through More Reports Similar to the Global Porcine Epidemic Diarrhea Vaccines Market 2026, By The Business Research Company

Porcine Epidemic Diarrhea Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Porcine Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795